Cargando…

Androgen Plays a Carcinogenic Role in EOC via the PI3K/AKT Signaling Pathway in an AR-Dependent Manner

Background: Epithelial ovarian cancer (EOC) is one of the most common gynecological cancers with the highest mortality rate. Studies indicate that androgens contribute to initiation or progression of EOC through poorly understood mechanisms, however, in the phase II clinical studies of antiandrogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanfang, Li, Sha, Zhang, Yizhou, Shi, Shuhong, Qin, Shan, Wang, Chang, Du, Juan, Ma, Jingle, Chen, Huan, Cui, Huixian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890324/ https://www.ncbi.nlm.nih.gov/pubmed/33613770 http://dx.doi.org/10.7150/jca.51099

Ejemplares similares

Non-genomic mechanisms mediate androgen-induced PSD95 expression
por: Zhang, Yizhou, et al.
Publicado: (2019)

The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
por: Peng, Peng, et al.
Publicado: (2019)

Carcinogenic Action of Androgens
por: Horning, E. S.
Publicado: (1958)

Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
por: Freedman, Ralph S, et al.
Publicado: (2004)

UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer
por: Cui, Ping, et al.
Publicado: (2022)

Exosomal LINC01213 Plays a Role in the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manners
por: Guo, Zhuifeng, et al.
Publicado: (2022)

MUC16 promotes EOC proliferation by regulating GLUT1 expression
por: Wang, Fang, et al.
Publicado: (2021)

CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2
por: He, Wei-Peng, et al.
Publicado: (2020)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells
por: Jen, Huan-I, et al.
Publicado: (2020)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
por: Dai, Lan, et al.
Publicado: (2022)

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)
por: Jim, Heather S.L., et al.
Publicado: (2015)

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
por: Chornokur, Ganna, et al.
Publicado: (2015)

SOS1 promotes epithelial-mesenchymal transition of Epithelial Ovarian Cancer(EOC) cells through AKT independent NF-κB signaling pathway
por: Cheng, Min, et al.
Publicado: (2021)

Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity
por: Hornig, N. C., et al.
Publicado: (2016)

Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance
por: Liu, Yu, et al.
Publicado: (2018)

High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2015)

AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways
por: Tortorella, Elisabetta, et al.
Publicado: (2023)

Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis
por: Fahmi, Moh Nailul, et al.
Publicado: (2021)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

Androgen receptor (AR) antagonism triggers acute succinate‐mediated adaptive responses to reactivate AR signaling
por: Saxena, Neetu, et al.
Publicado: (2021)

Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases
por: Chen, Junyu, et al.
Publicado: (2021)

Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
por: Giovannelli, Pia, et al.
Publicado: (2019)

Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction
por: Xu, Defeng, et al.
Publicado: (2017)

Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications
por: Zhao, Pei, et al.
Publicado: (2019)

Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino‐terminal domain
por: Hua, Yaping, et al.
Publicado: (2018)

Androgen-Induced MIG6 Regulates Phosphorylation of Retinoblastoma Protein and AKT to Counteract Non-Genomic AR Signaling in Prostate Cancer Cells
por: Schomann, Tim, et al.
Publicado: (2022)

Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
por: de Nóbrega, Monyse, et al.
Publicado: (2020)

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
por: Shorning, Boris Y., et al.
Publicado: (2020)

Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses
por: Chen, Zhonghua, et al.
Publicado: (2020)

Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
por: Zhang, Guanyi, et al.
Publicado: (2015)

ER/AR Multi-Conformational Docking Server: A Tool for Discovering and Studying Estrogen and Androgen Receptor Modulators
por: Wang, Feng, et al.
Publicado: (2022)

TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/β-catenin and Akt/mTOR signaling pathways
por: Kong, Lingling, et al.
Publicado: (2021)

Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes
por: Ismael, Nour El Hoda S., et al.
Publicado: (2019)

Regulation of androgen receptor splice variant AR3 by PCGEM1
por: Zhang, Ziqiang, et al.
Publicado: (2016)

Sex, androgens and regulation of pulmonary AR, TMPRSS2 and ACE2
por: Baratchian, Mehdi, et al.
Publicado: (2020)

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
por: Handle, Florian, et al.
Publicado: (2019)

Clinical values of expression signature of circCDR1AS and circHIAT1 in prostate cancer: Two circRNAs with regulatory function in androgen receptor (AR) and PI3K/AKT signaling pathways
por: Aghajani Mir, Mahsa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gj2rljarghjainkjvlthcmk6i